Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

Urruticoechea‐Arana, Ana; León-Vázquez, Fernando; Giner-Ruiz, Vicente; Andréu-Sánchez, José Luis; Olivé-Marques, Alejandro; Freire-González, Mercedes; Pego‐Reigosa, José María; Román-Ivorra, Jose Andrés; Alegre-Sancho, Juan José; Negrín, Francisco Vargas; Medina-Abellán, María; Cobo‐Ibáñez, Tatiana; Mas-Garriga, Xavier; Calvo‐Alén, Jaime; Costa-Ribas, Carmen; Blanco, Ricardo; Pérez-Martín, Álvaro; Beltrán-Catalán, Emma; Forcada-Gisbert, Jordi; Hernández-Miguel, María Victoria; Hermosa-Hernán, Juan Carlos; Narváez-García, Javier; Nieto-Pol, Enrique; Rúa-Figueroa, Íñigo

doi:10.1016/j.reumae.2019.09.001

Cited by 8 publications

(7 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ideally, mHealth solutions, such as mobile apps and wearable sensors could empower patients, provide individual support, and lead to better outcomes than those available through standard care. Patients with chronic rheumatic diseases already have access to a broad range of mHealth solutions, starting from symptom checkers [ 3 ] or referral tools [ 4 ]. Once a diagnosis is established, mHealth tools enable patients to better monitor their symptoms passively through sensors [ 5 ] and actively by entering data [ 6 , 7 ].…”

Section: Introductionmentioning

confidence: 99%

Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study

Knitza¹,

Simón²,

Lambrecht³

et al. 2020

JMIR Mhealth Uhealth

152

119

View full text Add to dashboard Cite

Background Mobile health (mHealth) defines the support and practice of health care using mobile devices and promises to improve the current treatment situation of patients with chronic diseases. Little is known about mHealth usage and digital preferences of patients with chronic rheumatic diseases. Objective The aim of the study was to explore mHealth usage, preferences, barriers, and eHealth literacy reported by German patients with rheumatic diseases. Methods Between December 2018 and January 2019, patients (recruited consecutively) with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis were asked to complete a paper-based survey. The survey included questions on sociodemographics, health characteristics, mHealth usage, eHealth literacy using eHealth Literacy Scale (eHEALS), and communication and information preferences. Results Of the patients (N=193) who completed the survey, 176 patients (91.2%) regularly used a smartphone, and 89 patients (46.1%) regularly used social media. Patients (132/193, 68.4%) believed that using medical apps could be beneficial for their own health. Out of 193 patients, only 8 (4.1%) were currently using medical apps, and only 22 patients (11.4%) stated that they knew useful rheumatology websites/mobile apps. Nearly all patients (188/193, 97.4%) would agree to share their mobile app data for research purposes. Out of 193 patients, 129 (66.8%) would regularly enter data using an app, and 146 patients (75.6%) would welcome official mobile app recommendations from the national rheumatology society. The preferred duration for data entry was not more than 15 minutes (110/193, 57.0%), and the preferred frequency was weekly (59/193, 30.6%). Medication information was the most desired app feature (150/193, 77.7%). Internet was the most frequently utilized source of information (144/193, 74.6%). The mean eHealth literacy was low (26.3/40) and was positively correlated with younger age, app use, belief in benefit of using medical apps, and current internet use to obtain health information. Conclusions Patients with rheumatic diseases are very eager to use mHealth technologies to better understand their chronic diseases. This open-mindedness is counterbalanced by low mHealth usage and competency. Personalized mHealth solutions and clear implementation recommendations are needed to realize the full potential of mHealth in rheumatology.

show abstract

Section: Introductionmentioning

confidence: 99%

Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study

Knitza¹,

Simón²,

Lambrecht³

et al. 2020

JMIR Mhealth Uhealth

152

119

View full text Add to dashboard Cite

show abstract

“…One possibility might be the PCPs, as up to 83% of PCPs may recommend apps 44 and apps have been developed for use in primary care. 45,46 PMR was the behavioral intervention used in this study and future studies might consider adapting and assessing other behavioral interventions for migraine in a smartphone so that it can be potentially delivered in a scalable, accessible manner. Lastly, as with all mHealth studies, there should be continued work on how to improve adherence to the mHealth intervention.…”

Section: Discussionmentioning

confidence: 99%

“…Future research should examine (1) the dose of PMR needed for optimal benefit both at the population level and for particular individuals; (2) the efficacy of this intervention in a larger, pragmatic implementation trial; (3) whether certain patient characteristics identify who might benefit the most from this self‐driven intervention; (4) whether there is a reduction in medication use, healthcare utilization, and any psychiatric comorbidities or overlapping pain conditions; and (5) who might be best to introduce the intervention. One possibility might be the PCPs, as up to 83% of PCPs may recommend apps 44 and apps have been developed for use in primary care 45,46 . PMR was the behavioral intervention used in this study and future studies might consider adapting and assessing other behavioral interventions for migraine in a smartphone so that it can be potentially delivered in a scalable, accessible manner.…”

Section: Discussionmentioning

confidence: 99%

Smartphone‐Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial

Minen

Adhikari

Padikkala³

et al. 2020

Headache

View full text Add to dashboard Cite

Objective.-Scalable, accessible forms of behavioral therapy for migraine prevention are needed. We assessed the feasibility and acceptability of progressive muscle relaxation (PMR) delivered by a smartphone application (app) in the Primary Care setting. Methods.-This pilot study was a non-blinded, randomized, parallel-arm controlled trial of adults with migraine and 4+ headache days/month. Eligible participants spoke English and owned a smartphone. All participants were given the RELAXaHEAD app which includes an electronic headache diary. Participants were randomized to receive 1 of the 2 versions of the app-one with PMR and the other without PMR. The primary outcomes were measures of feasibility (adherence to the intervention and diary entries during the 90-day interval) and acceptability (satisfaction levels). We conducted exploratory analyses to determine whether there was a change in Migraine Disability Assessment Scale (MIDAS) scores or a change in headache days. Results.-Of 139 participants (77 PMR, 62 control), 116 (83%) were female, mean age was 41.7 ± 12.8 years. Most patients 108/139 (78%) had moderate-severe disability. Using a 1-5 Likert scale, participants found the app easy to use (mean 4.2 ± 0.7) and stated that they would be happy to engage in the PMR intervention again (mean 4.3 ± 0.6). For the first 6 weeks, participants practiced PMR 2-4 days/week. Mean per session duration was 11.1 ± 8.3 minutes. Relative to the diaryonly group, the PMR group showed a greater non-significant decline in mean MIDAS scores (−8.7 vs −22.7, P = .100) corresponding to a small-moderate mean effect size (Cohen's d = 0.38). Conclusion.-Smartphone-delivered PMR may be an acceptable, accessible form of therapy for migraine. Mean effects show a small-moderate mean effect size in disability scores.

show abstract

“…So hat z. B. die spanische Fachgesellschaft für Rheumatologie in Kooperation mit der spanischen Fachgesellschaft für Hausärzte eine App entwickelt, die einen klaren Diagnostik-und Überweisungsalgorithmus für Patienten mit muskuloskeletalen Beschwerden vorgibt [18].…”

Section: Apps Zur Diagnoseunterstützungunclassified

Apps und ihre Anwendungsgebiete in der Rheumatologie

Krusche

Ruffer

Grahammer³

et al. 2020

Z Rheumatol

View full text Add to dashboard Cite

ZusammenfassungMit der steigenden Verwendung von Smartphones einhergehend, nimmt auch die Nutzung von mobilen Applikationen (Apps) rapide zu. Im medizinischen Kontext könnten chronisch kranke Patienten von dem Einsatz dauerhaft profitieren. Verstärkt wird diese Entwicklung durch das Digitale-Versorgung-Gesetz (DVG), wonach Patienten ab Q4/2020 einen Rechtsanspruch auf bestimmte Apps, sog. digitale Gesundheitsanwendungen (DiGAs), haben, die von den gesetzlichen Krankenkassen erstattet werden. Besonders im Bereich der Rheumatologie bieten sich für das Management chronischer Erkrankungen und ihrer Komorbiditäten verschiedene Anknüpfungspunkte. Nicht nur unter rheumatologischen Patienten ist das Interesse an App-Angeboten groß, sondern auch unter deutschen Rheumatologen zeigt sich eine steigende Bereitschaft, Apps im Berufsalltag anzuwenden und Patienten zu empfehlen. Dieser Artikel will einen Überblick über die Entwicklung der App-Landschaft in der deutschsprachigen Rheumatologie vermitteln.

show abstract

Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

Cited by 8 publications

References 4 publications

Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study

Mobile Health Usage, Preferences, Barriers, and eHealth Literacy in Rheumatology: Patient Survey Study

Smartphone‐Delivered Progressive Muscle Relaxation for the Treatment of Migraine in Primary Care: A Randomized Controlled Trial

Apps und ihre Anwendungsgebiete in der Rheumatologie

Contact Info

Product

Resources

About